EnerSys_Logo.jpg
EnerSys CEO David M. Shaffer to Present at the Oppenheimer 17th Annual Industrial Growth Conference May 3, 2022
April 19, 2022 16:15 ET | EnerSys
READING, Pa., April 19, 2022 (GLOBE NEWSWIRE) -- EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications, announced today that David M. Shaffer, President and...
2019 logo_150x35_jpg.jpg
Novan, Inc. to Present at Two Upcoming Investor Conferences
March 14, 2022 09:00 ET | Novan, Inc.
DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
logo.jpg
Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
March 10, 2022 08:30 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...
Atyr_Logo.png
aTyr Pharma to Present at Upcoming Investor Conferences in March
March 03, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Synlogic Logo (no background).png
Synlogic To Present at Upcoming Investor and Industry Conferences
February 24, 2022 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
October 07, 2021 16:05 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock...
Dimond Kaplan & Rothstein, P.A. Logo
ATTENTION HORIZON PRIVATE EQUITY III INVESTORS: Law Firm Dimond Kaplan & Rothstein, P.A. is Investigating Claims Against Oppenheimer for Customers Who Lost Money in Horizon Private Equity III Alleged Ponzi Scheme
September 23, 2021 11:29 ET | Dimond Kaplan & Rothstein, P.A.
MIAMI and LOS ANGELES, Sept. 23, 2021 (GLOBE NEWSWIRE) -- National investment fraud law firm Dimond Kaplan & Rothstein, P.A. (“DKR”) (http://www.dkrpa.com) is investigating potential claims...
Atyr_Logo.png
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 16, 2021 16:01 ET | aTyr Pharma, Inc.
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Form fit function.png
Conformis, Inc. to Participate in Upcoming Investor Conferences
September 07, 2021 17:00 ET | Conformis, Inc.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products,...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 14, 2021 09:00 ET | Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...